{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:10:04Z","timestamp":1756375804680,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,10,17]]},"abstract":"<jats:p>Delayed haemolytic transfusion reaction is a rare, life-threatening complication of blood transfusion that has been typically described among patients with sickle cell disease (SCD) due to alloimmunisation induced by their exposure to red blood cell antigens through recurrent transfusions. We report the case of a patient who suffered from fatal delayed haemolytic transfusion reaction (DHTR) occurring 1\u2009week after blood transfusion. Indirect antiglobulin testing confirmed the presence of anti-Kell antibodies that were absent in the pretransfusion sample. The patient did not receive blood transfusions in the past, but her obstetric history was remarkable for 13 pregnancies. Although DHTR occurs more commonly among patients with SCD, this type of reaction can occur in any patient who is able to mount an immune response. We would to like to draw the attention of physicians to this rare and potentially lethal complication of blood transfusion, especially in grand multiparous women.<\/jats:p>","DOI":"10.1136\/bcr-2017-222343","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T02:40:18Z","timestamp":1509763218000},"page":"bcr-2017-222343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Fatal delayed haemolytic transfusion reaction in a patient without previous transfusions but with an obstetric history of 13 pregnancies"],"prefix":"10.1136","volume":"2017","author":[{"given":"Evgeni","family":"Chubar","sequence":"first","affiliation":[{"name":"Emek Medical Center, Afula, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-1701","authenticated-orcid":false,"given":"Naiel","family":"Bisharat","sequence":"additional","affiliation":[{"name":"Emek Medical Center, Afula, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.1","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"The Lancet"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tracli.2017.05.016","article-title":"Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment","volume":"24","author":"Pirenne","year":"2017","journal-title":"Transfus Clin Biol"},{"issue":"7-8 Pt 2","key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.3","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/j.lpm.2016.06.024","article-title":"Immunological complications of blood transfusions","volume":"45","author":"Brand","year":"2016","journal-title":"Presse Med"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30891020325.x"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.5","doi-asserted-by":"crossref","first-page":"1062.e5","DOI":"10.1016\/j.ajem.2010.01.032","article-title":"Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review","volume":"28","author":"El-Husseini","year":"2010","journal-title":"Am J Emerg Med"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1537-2995.1978.18178118550.x","article-title":"Transfusion reaction. An immunologic hazard of blood transfusion","volume":"18","author":"Pineda","year":"1978","journal-title":"Transfusion"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.transci.2012.07.020","article-title":"Fatal delayed hemolytic transfusion reaction associated with anti-Di(b) and anti-E","volume":"47","author":"Hatano","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.8","first-page":"498","article-title":"[Fatal delayed hemolytic transfusion reaction in a postoperative case of traumatic aortic rupture]","volume":"43","author":"Shigeta","year":"1990","journal-title":"Kyobu Geka"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1537-2995.1979.19580059807.x","article-title":"Fatal delayed hemolytic transfusion reaction due to anti-c+E","volume":"19","author":"Hillman","year":"1979","journal-title":"Transfusion"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-110-3-241","article-title":"Fatal delayed hemolytic transfusion reaction without previous blood transfusion","volume":"110","author":"Schorn","year":"1989","journal-title":"Ann Intern Med"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.6.e661"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","article-title":"Hyperhemolytic transfusion reaction in sickle cell disease","volume":"41","author":"Win","year":"2001","journal-title":"Transfusion"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/OGX.0b013e3182947ce4","article-title":"Mechanisms and prevention of alloimmunization in pregnancy","volume":"68","author":"Kjeldsen-Kragh","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05425.x"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.16","doi-asserted-by":"publisher","DOI":"10.1159\/000086406"},{"key":"2025082802353816000_2017.nov03_1.bcr-2017-222343.17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000369145","article-title":"Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?","volume":"41","author":"Tatari-Calderone","year":"2014","journal-title":"Transfus Med Hemother"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:35:45Z","timestamp":1756373745000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":17,"alternative-id":["10.1136\/bcr-2017-222343"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222343","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}